Evidence map›Paper›PMID 33182408›Full record

ArticleAntioxidants (Basel, Switzerland)2020

Clinical and Molecular-Genetic Insights into the Role of Oxidative Stress in Diabetic Retinopathy: Antioxidant Strategies and Future Avenues.

Silvia M Sanz-González, José J García-Medina, Vicente Zanón-Moreno, María I López-Gálvez, David Galarreta-Mira, Lilianne Duarte, Mar Valero-Velló, Ana I Ramírez, J Fernando Arévalo, María D Pinazo-Durán and 1 more

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Observational
  3. Article
  4. Article
  5. Review
  6. Article
  7. Resilience to diabetic retinopathy.Progress in retinal and eye research · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Mechanism of the antidiabetic action ofFrontiers in nutrition · 2023
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Silvia M Sanz-GonzálezOphthalmic Research Unit "Santiago Grisolía", Fundación Investigación Sanitaria y Biomédica (FISABIO), Ave. Gaspar Aguilar 90, 46017 Valencia, Spain.
José J García-MedinaOphthalmic Research Unit "Santiago Grisolía", Fundación Investigación Sanitaria y Biomédica (FISABIO), Ave. Gaspar Aguilar 90, 46017 Valencia, Spain.ORCID 0000-0002-6245-7271
Vicente Zanón-MorenoOphthalmic Research Unit "Santiago Grisolía", Fundación Investigación Sanitaria y Biomédica (FISABIO), Ave. Gaspar Aguilar 90, 46017 Valencia, Spain.ORCID 0000-0003-1179-1592
María I López-GálvezSpanish Net of Ophthalmic Research "OFTARED" RD16/0008/0022, of the Institute of Health Carlos III, 28029 Madrid, Spain.
David Galarreta-MiraSpanish Net of Ophthalmic Research "OFTARED" RD16/0008/0022, of the Institute of Health Carlos III, 28029 Madrid, Spain.
Lilianne DuarteDepartment of Ophthalmology, Complexo Hospitalar "Entre Douro e Vouga", 4520-211 Santa Maria da Feira, Portugal.ORCID 0000-0003-3953-0730
Mar Valero-VellóOphthalmic Research Unit "Santiago Grisolía", Fundación Investigación Sanitaria y Biomédica (FISABIO), Ave. Gaspar Aguilar 90, 46017 Valencia, Spain.
Ana I RamírezSpanish Net of Ophthalmic Research "OFTARED" RD16/0008/0022, of the Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-2656-4723
J Fernando ArévaloWilmer s Eye Institute at the Johns Hopkins Hospital, Baltimore, MD 21287, USA.
María D Pinazo-DuránOphthalmic Research Unit "Santiago Grisolía", Fundación Investigación Sanitaria y Biomédica (FISABIO), Ave. Gaspar Aguilar 90, 46017 Valencia, Spain.ORCID 0000-0002-0118-7837
On Behalf Of The Valencia Study Group On Diabetic Retinopathy Vsdr Report Number
Universitat de València · ESInstituto de Salud Carlos III · ESFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESJohns Hopkins Hospital · USUnidade Local de Saúde de Entre Douro e Vouga · PTUniversidad Complutense de Madrid · ES

Funding

Instituto de Salud Carlos III PI13/00480Instituto de Salud Carlos III PI16/00797Instituto de Salud Carlos III RD16/0008/0001Instituto de Salud Carlos III RD16-0008/0005Instituto de Salud Carlos III RD16-008/0022Thea Laboratories research fellowship from S.M.S-G
6 · The paper itself

Abstract

Reactive oxygen species (ROS) overproduction and ROS-signaling pathways activation attack the eyes. We evaluated the oxidative stress (OS) and the effects of a daily, core nutritional supplement regimen containing antioxidants and omega 3 fatty acids (A/ω3) in type 2 diabetics (T2DM). A case-control study was carried out in 480 participants [287 T2DM patients with (+)/without (-) diabetic retinopathy (DR) and 193 healthy controls (CG)], randomly assigned to a daily pill of A/ω3. Periodic evaluation through 38 months allowed to outline patient characteristics, DR features, and classic/OS blood parameters. Statistics were performed by the SPSS 24.0 program. Diabetics displayed significantly higher circulating pro-oxidants (

Indexed as

antioxidantscandidate biomarkersomega-3 fatty acidsoxidative stressprevention of blindnessretinopathytype 2 diabetes mellitus

Identifiers

PMID33182408
PMCPMC7697026
OpenAlexW3103530306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.